Home
Rolf Kristian Berge's picture

Rolf Kristian Berge

Professor
  • E-mailRolf.Berge@uib.no
  • Phone+47 55 97 30 98
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • 2009. The absorption, distribution and biological effects of a modified fatty acid in its free form and as an ethyl ester in rats. Chemico-Biological Interactions. 227-232.
  • 2009. The absorption, distribution and biological effects of a modified fatty acid in its free form and as an ethyl ester in rats. Chemico-Biological Interactions. 227-232.
  • 2009. Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation. Diabetes, obesity and metabolism. 304-314.
  • 2009. Synthesis and Analysis of Novel Glycerolipids for the Treatment of Metabolic Syndrome. Journal of Medicinal Chemistry. 1172-1179.
  • 2009. Reduced sexual maturation in male post-smolt 1+Atlantic salmon (Salmo salar L.) by dietary tetradecylthioacetic acid. Aquaculture Research. 533-541.
  • 2009. Increased survival by feeding tetradecylthioacetic acid during a natural outbreak of heart and skeletal muscle inflammation in S0 Atlantic salmon, Salmo salar L. Journal of Fish Diseases. 953-961.
  • 2009. Increased survival by feeding tetradecylthioacetic acid during a natural outbreak of heart and skeletal muscle inflammation in S0 Atlantic salmon, Salmo salar L. Journal of Fish Diseases. 953-961.
  • 2009. Dietary supplementation of tetradecylthioacetic acid increases feed intake but reduces body weight gain and adipose depot sizes in rats fed on high-fat diets. Diabetes, obesity and metabolism. 1034-1049.
  • 2009. A complex role of activin A in non-alcoholic fatty liver disease. American Journal of Gastroenterology. 2196-2205.
  • 2009. A casein diet added isoflavone-enriched soy protein favorably affects biomarkers of steatohepatitis in obese Zucker rats. Nutrition - The International Journal of Applied and Basic Nutritional Sciences. 574-580.
  • 2008. Pharmacology and safety of tetradecylthioacetic acid (TTA): phase-1 study. Journal of Cardiovascular Pharmacology. 410-417.
  • 2008. Long term treatment with tetradecylthioacetic acid improves the antioxidant status in obese Zucker (fa/fa) rats. Drug Metabolism Letters. 138-145.
  • 2008. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice. Journal of Molecular and Cellular Cardiology. 201-209.
  • 2007. Influence of dietary conjugated linoleic acid (CLA) and tetradecylthioacetic acid (TTA) on growth, lipid composition and key enzymes of fatty acid oxidation in liver and muscle of Atlantic cod (Gadus morhua L.). Aquaculture. 372-382.
  • 2007. Effects of dietary thia fatty acids on lipid composition, morphology and macrophage function of Atlantic salmon (Salmo salar L.) kidney. Comparative Biochemistry and Physiology - Part B: Biochemistry & Molecular Biology. 103-111.
  • 2007. Dose-dependent coronary artery intimal thickening after local delivery of the anti-oxidant tetradecylthioacetic acid from stents. Atherosclerosis. e39-e47.
  • 2007. Does the capacity for energy utilization affect the survival of post-smolt Atlantic salmon, Salmo salar L., during natural outbreaks of infectious pancreatic necrosis? Journal of Fish Diseases. 399-409.
  • 2007. Differential effect of tetradecythioacetic acid on the renin-angiotensin system and blood pressure in SHR and 2-kidney, 1-clip hypertension. American Journal of Physiology - Renal, fluid and electrolyte physiology. F839-845.
  • 2006. Thia fatty acids with the sulfur atom in even or odd positions have opposite effects on fatty acid catabolism. Lipids. 169-177.
  • 2006. Prevention of Hypertension and Organ Damage in 2-Kidney, 1-Clip Rats by Tetradecylthioacetic Acid. Hypertension. 460-466.
  • 2006. Effects of 3-thia fatty acids on expression of some lipid related genes in Atlantic salmon (Salmo salar L.). Comparative Biochemistry and Physiology - Part B: Biochemistry & Molecular Biology. 239-248.
  • 2006. Dietary soya protein concentrate enriched with isoflavones reduced fatty liver, increased hepatic fatty acid oxidation and decreased the hepatic mRNA level of VLDL receptor in obese Zucker rats. British Journal of Nutrition. 249-257.
  • 2006. Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver. Journal of Lipid Research. 2223-2232.
  • 2006. A bioactively modified fatty acid improves survival and impairs metastasis in preclinical models of acute leukemia. Clinical Cancer Research. 3525-3531.
  • 2005. The metabolic syndrome and the hepatic fatty acid drainage hypothesis. Biochimie. 15-20.
  • 2005. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 1058-1065.
  • 2005. Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflammatory Bowel Diseases. 744-748.
  • 2005. In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum. Journal of Cancer Research and Clinical Oncology. 377-384.
  • 2005. Glucose-induced lipogenesis in pancreatic beta-cells is dependent on SREBP-1. Molecular and Cellular Endocrinology. 94-106.
  • 2005. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Alimentary Pharmacology and Therapeutics. 831-838.
  • 2005. Effect of 18 : 1n-9, 20 : 5n-3, and 22 : 6n-3 on lipid accumulation and secretion by Atlantic salmon hepatocytes. Lipids. 477-486.
  • 2005. Down-regulated expression of PPAR alpha target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNF alpha. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids. 235-246.
  • 2005. Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action? The Pharmacogenomics Journal. 298-304.
  • 2005. Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways. Arteriosclerosis, Thrombosis and Vascular Biology. 1364-1369.
  • 2004. Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy. European Journal of Clinical Investigation. 709-715.
  • 2004. Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy. European Journal of Clinical Investigation. 709-715.
  • 2004. Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA : Cholesterol acyltransferase activity in liver of Zucker rats. Journal of Nutrition. 1320-1327.
  • 2004. Effects of 3-thia fatty acids on feed intake, growth, tissue fatty acid composition, beta-oxidation and Na+,K+-ATPase activity in Atlantic salmon. Comparative Biochemistry and Physiology - Part B: Biochemistry & Molecular Biology. 657-658.
  • 2003. Immunomodulating effects of 3-thia fatty acids in activated peripheral blood mononuclear cells. European Journal of Clinical Investigation. 426-433.
  • 2003. Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy - potential immunomodulatory effects of antioxidants. Journal of Infectious Diseases. 232-238.
  • 2003. Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia. American Journal of Clinical Nutrition. 117-122.
  • 2003. Changed energy state and increased mitochondrial beta-oxidation rate in liver of rats associated with lowered proton electrochemical potential and stimulated uncoupling protein 2 (UCP-2) expression. Journal of Biological Chemistry. 30525-30533.
  • 2003. Cataract formation in Atlantic salmon, Salmo salar L., smolt relative to dietary pro- and antioxidants and lipid levels. Journal of Fish Diseases. 213-229.
  • 2003. Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases. Journal of Lipid Research. 2320-2330.
  • 2002. Tetradecylthioacetic acid prevents high fat diet induced adiposity and insulin resistance. Journal of Lipid Research. 742-750.
  • 2002. Tetradecylthioacetic acid prevents high fat diet induced adiposity and insulin resistance. Journal of Lipid Research. 742-750.
  • 2002. Metabolic effects of thia fatty acids. Current Opinion in Lipidology. 295-304.
  • 2002. Human TNFa in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes. The FASEB Journal.
  • 2002. Human TNF- alfa in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes. The FASEB Journal. 1450-1452.
  • 2002. Evidence for selective induction of phosphoenolpyruvate carboxykinase gene expression by unsaturated and nonmetabolized fatty acids in adipocytes. Journal of Cellular Biochemistry. 651-661.
  • 2002. Antiproliferative effects of a non-beta-oxidizable fatty acid, tetradecylthioacetic acid, in native human acute myelogenous leukemia blast cultures. Leukemia. 2292-2301.
  • 2001. Tetradecylthioacetic acid reduces stenosis development after balloon angioplasty injury of rabbit iliac arteries. Atherosclerosis. 269-275.
  • 2001. Omega-3 fatty acids enhance tumor necrosis factor-alfa levels in heart transplant recipients. Transplantation. 706-711.
  • 2001. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. Journal of the American College of Cardiology. 485-491.
  • 2001. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. Journal of the American College of Cardiology. 485-491.
  • 2001. Growth reduction in glioma cells after treatment with tetradecylthioacetic acid: changes in fatty acid metabolism and oxidative status. Biochemical Pharmacology. 639-649.
  • 2001. Effect of long-chain n-3 and mono-unsaturated fatty acids on fatty acid oxidation and lipid composition in rats. Annals of Nutrition and Metabolism. 30-37.
  • 2000. Virological and immunological effects of antioxidant treatment in patients with HIV infection. European Journal of Clinical Investigation. 905-14.
  • 2000. Virological and immunological effects of antioxidant treatment in patients with HIV infection. European Journal of Clinical Investigation. 905-914.
  • 2000. Virological and immunological effects of antioxidant treatment in patients with HIV infection. European Journal of Clinical Investigation. 905-914.
  • 2000. Tetradecylthioacetic acid and tetradecylselenoacetic acid inhibit lipid eroxidation and interact with superoxide radical. Free Radical Biology & Medicine. 1068-1078.
  • 2000. Proliferation of mitochondria and gene expression of carnitine palmitoyltransferase and fatty acyl-CoA oxidase in rat skeletal muscle, heart and liver by hypolipidemic fatty acids. Biology of the Cell. 317-329.
  • 2000. Preparation and NMR studies of 3-selenaheptadecanoic and 4-selenaoctadecanoic acid, RSe(CH2)nC(O)OH (R = -C14H29, n = 1 and 2), and their methyl esters. Journal of the Chemical Society. Perkin Transactions 2 (2001). 723-729.
  • 2000. Peroxisome Proliferator-activated Receptor a Activators Improve Insulin Sensitivity and Reduce Adipoisty. Journal of Biological Chemistry. 16638-16642.
  • 2000. Long-chain acyl-CoA esters and acyl-CoA binding protein are present in the nucleus of rat liver cells. Journal of Lipid Research. 538-545.
  • 2000. Long-chain acyl-CoA esters and acyl-CoA binding protein are present in the nucleus of rat liv er cells. Journal of Lipid Research. 538-545.
  • 2000. Decreased vitamin A levels in common variable immunodeficiency - vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses. European Journal of Clinical Investigation. 252-259.
  • 2000. Correlation between Plasma Total Homocysteine and Copper in Patients with Peripheral Vascular Disease. Clinical Chemistry. 385-391.
  • 2000. 2,2'-Selenobis(acetic acid), Se(CH2C(o)OH)2: an old compound with a novel structure. Journal of Molecular Structure. 149-161.
  • 1999. Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARa activation. Journal of Lipid Research. 2099-2110.
  • 1999. Metochondrial 3-Hydroxy-3-Methylglutaryl Coenzyme A Synthase and Carnitine Palmitoyltransferase II as Potential Control sites for Ketogenesis during Mitochondrion and Peroxisome Proliferation. Biochemical Pharmacology. 1011-1019.
  • 1999. Methylated eicosapentaenoic acid and tetradecylthioacetic acid: effects on fatty acid metabolism. Biochemical Pharmacology. 1133-1143.
  • 1999. Methylated eicosapentaenoic acid and tetradecylthioacetic acid: Effects on fatty acid metabolism. Biochemical Pharmacology. 1133-1143.
  • 1999. In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacyllycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation. Biochemical Journal. 191-197.
  • 1999. In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation. Biochemical Journal. 191-197.
  • 1999. Eicosapentaenoic and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference. Lipids. 951-963.
  • 1999. Eicosapentaenoic and docosahexaenoic Acid Affect Mitochondrial and Peroxisomal Fatty Acid Oxidation in Relation to Substrate Preference. Lipids. 951-963.
  • 1999. Eicosapentaenoic acid and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference. Lipids. 951-963.
  • 1999. Beneficial Effects of Fibrates on Apolipoprotein A-I Metabolism Occur Independently of Any Peroxisome Proliferative Response. Circulation. 2445-2451.
  • 1999. 3-Thia Fatty Acid Treatment, in Contrast to Eicosapentaenoic Acid and Starvation, Induces Gene Expression of Carnitine Palmitoyltransferase-II in Rat Liver. Lipids. 447-456.
  • 1998. Turnover of _a-, _g-, and _b-tocopherol and distribution in subcellular and lipoprotein fraction indicate presence of an hepatic tocopherol binding protein in Atlantic salmon (<i>Salmo salar L</i>). Fish Physiology & Biochemistry. 71-83.
  • 1998. On the effect of 2-deuterium- and 2-methyl-eicosapentaenoic acid derivatives on triglycerides, peroxisomal beta-oxidation and platelet aggregation in rats. Biochimica et Biophysica Acta. 193-203.
  • 1998. On the effect of 2-deuterium and 2-methyl-eicosapentaenoic acid derivatives on triglycerides, peroxisomal _b-oxidation and platelet aggregation in rats. Biochimica et Biophysica Acta. 193-203.
  • 1998. Lipid peroxidation of isolated chylomicrons and oxidative status in plasma after prolonged intake of highly purified eicosapentaenoic (EPA) or docosahecaenoic (DHA) acids. Lipids. 1123-1129.
  • 1998. Influence of treatment with aminoglutethimide on plasma and red-blood-cell gluthatione status in breast cancer patients. Cancer Chemotherapy and Pharmacology. 46-52.
  • 1998. Hypolipidemic n-3 fatty acids increases the antioxidant defence system to inhibit increased plasma and LDL lipid peroxidation. Lipids. 1131-1137.
  • 1998. Generalized peroxisomal disorder in male twins: Fatty acid composition of serum lipids and response to n-3 fatty acids. Journal of Inherited Metabolic Disease. 662-670.
  • 1998. Generalized peroxisomal disorder in male twins: Fatty acid composition of serum lipids and response to n-3 fatty acids. Journal of Inherited Metabolic Disease. 662-670.
  • 1998. Generalized peroxisomal disorder in male twins: Fatty acid composition of serum lipids and response to n -3 fatty acids. Journal of Inherited Metabolic Disease. 662-670.
  • 1998. Effects of Simvastatin and omega-3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia. Journal of Internal Medicine. 163-170.
  • 1998. Docosahexaenoic and eicosapentaenoic acids are differently metabolized in rat liver during mitochondria and peroxisome proliferation. Journal of Lipid Research. 583-593.
  • 1998. Docosahexaenoic and eicosapentaenoic acids are differently metabolized in rat liver during mitochondria and peroxisome proliferation. Journal of Lipid Research. 583-593.
  • 1998. Disruption of a regulatory system involving cobalamin distribution and function in a methionine-dependent human glioma cell line. Journal of Biological Chemistry. 20180-20184.
  • 1998. Disruption of a Regulatory system Involving Cobalamin distribution and Function in a Methionine-dependent Human glioma Cell Line. Journal of Biological Chemistry. 20180-20184.
  • 1998. Carnitine Palmitloyltransferase I, Carnitine Palmityltransferase II, and Acyl-CoA Oxidase Activities in Atlantic Salmon (<i>Salmo slar</i>). Lipids. 923-930.
  • 1998. Acute modulation of genes encoding peroxisomal and mitochondrial _b-oxidation enzymes by 3-thia fatty acids. Biochemical Pharmacology. 1571-1582.
  • 1997. Vitamins C and E interact in juvenile Atlantic salmon (Salmo salar, L). Free Radical Biology & Medicine. 137-149.
  • 1997. Upregulated delta-9-desaturase gene expression by hypolipidemic, peroxisome-proliferating fatty acids results in increased oleic acid in liver and VLDL: accumulation of a delta-9-desaturated metabolite of tetradecylthioacetic acid. Journal of Lipid Research. 554-563.
  • 1997. Up-regulated _D(9)-desaturase gene expression by hypolipidemic peroxisome-proliferating fatty acids results in increased oleic acid content in liver and VLDL: Accumulation of a _D(9)-desaturated metabolite of tetradecylthioacetic acid. Journal of Lipid Research. 554-563.
  • 1997. Tetradecylthioacetic acid inhibits the oxidative modification of low density lipoprotein and 8-hydroxydeoxyguanosine formation in vitro. Arteriosclerosis, Thrombosis and Vascular Biology. 3255-3262.
  • 1997. Tetradecylthioacetic acid inhibits the oxidative modification of low density lipoprotein and 8-hydroxydeoxyguanosine formation in vitro. Arteriosclerosis, Thrombosis and Vascular Biology. 3255-3262.
  • 1997. Tetradecylthioacetic Acid Inibits the Oxidative Modification of Low Density Lipoprotein and 8-Hydroxydeoxyguanosine formation in Vitro. Arteriosclerosis, Thrombosis and Vascular Biology.
  • 1997. On the effects of thia fatty acid analogues on hydrolases involved in the degradation of metabolisable and non-metabolisable acyl-CoA esters. Xenobiotica. 197-202.
  • 1997. Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism. Journal of Lipid Research. 183-190.
  • 1997. Mitochondrion is the principal target for nutitional and pharmacological control of triglyceride metabolism. Journal of Lipid Research. 183-190.
  • 1997. Hypotriacylglycerolemic component of fish oil. Prostaglandins, Leukotrienes and Essential Fatty Acids. 387-388.
  • 1997. Enhanced hepatic faty acid oxidation and unpregulated carnitiue palmitoyl-transferance II gene expression by methyl 3-tharoctadeca6,9,12,15 - tetraenoate in rats. Journal of Lipid Mediators and Cell Signalling. 115-134.
  • 1997. Enhanced hepatic fatty acid oxidation and unpregulated carnitinu palmitoyl-transferase II gene expression by methyl 3-tharoctadeca6,9,12,15 - tetraenoate in rats. Journal of Lipid Mediators and Cell Signalling. 115-134.
  • 1997. Enhanced fatty acid oxidation and upregulated carnitine palmitoyl- transferase II gene expression by methyl 3-thiaoxadeca-6,9,12,15- tetraenoate in rats. Journal of Lipid Mediators and Cell Signalling. 115-134.
  • 1997. Elevated plasma levels of reduced homocysteine in common variable immunodeficiency - a marker of enhanced oxidative stress. European Journal of Clinical Investigation. 723-730.
  • 1997. Elevated plasma levels of reduced homocysteine in common variable immunodeficiency - a marker of enhanced oxidative stress. European Journal of Clinical Investigation. 730-790.
  • 1997. Elevated plasma levels of reduced homocysteine in common variable immunodeficiency - a marker of enhanced oxidative stress. European Journal of Clinical Investigation. 723-730.
  • 1997. Eikcosapentaenoic acid and sulphur substituted fatty acid analogues inhibit the proliferation of human breast cancer cells in culture. Breast Cancer Research and Treatment. 229-239.
  • 1997. Effect of 3-thia fatty acids on the lipid composition of rat liver, lipoproteins, and heart. Journal of Lipid Research. 1522-1534.
  • 1997. 1-@(Carboxymethylthio@)-tetradecane attenuates PDGF- and TPA-induced c-fos mRNA expression and increases the formation of phosphatidylethanolamine with a shift from less to more polar molecular species in C3H/10 1/2 mouse fibroblasts. Experimental Cell Research. 330-340.
  • 1997. 1-@(Carboxymethylthio@)-tetradecane attenuates PDGF- and TPA-induced c-fos mRNA expression and increases the formation of phosphatidylethanolamine with a shift from less to more polar molecular species in C3H/10 1/2 mouse fibroblasts. Experimental Cell Research. 330-340.
  • 1996. Peroxisomal fatty acid oxidation capacity is more resistant to ischaemic and reperfusion injury than mitochondrial fatty acid oxidation capacity in feline hearts. Acta Physiologica Scandinavica. 133-145.
  • 1996. Long-term effect of tetradecylthioacetic acid: a study on lipid profile and fatty acid composition and oxidation in different rat organs. Biochimica et Biophysica Acta. 86-96.
  • 1996. Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2,4-dienoyl-CoA reductase gene expression in rats. Lipids. 579-592.
  • 1996. Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2,4-dienoyl-CoA reductase gene expression. Lipids. 579-592.
  • 1996. Chronic administration of eicosapentaenoic acid and docosahexaenoic acid as ethyl esters reduced plasma cholesterol and changed fatty acid composition in rat blood and organs. Lipids. 169-178.
  • 1996. Carvedilol protects against lethal reperfusion injury through antiadrenergic mechanisms. Journal of Cardiovascular Pharmacology. 409-417.
  • 1996. Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury. European Journal of Pharmacology. 99-107.
  • 1996. A hypolipidemic peroxisome proliferating fatty acid induces polydispersity of rat liver mitochondria. Biology of the Cell. 105-112.
  • 1996. 3-Thia fettsyrer - et nytt lipidsenkende legemiddel? NBS-nytt. 6-11.
  • 1995. Tetradecylthioacetic acid (a 3-thia fatty acid) decreases triacylglycerol secretion in CaCo-2 cells. Journal of Lipid Research. 535-543.
  • 1995. Hepatic fatty acid metabolism as a determinant of plasma and liver triacylglycerol levels. Studies on tetradecylthioacetic and tetradecylthiopropionic acids. European Journal of Biochemistry (EJB). 715-722.
  • 1995. Fatty acid-CoA oxidase activity is induced before long-chain acyl-CoA hydrolase activity and acyl-CoA binding protein in liver of rats treated with peroxisome proliferating 3-thia fatty acids. Xenobiotica. 1181-1194.
  • 1995. Eicosapentaenoic acid causes transient accumalation of lipids in rat myocardium. Biochimica et Biophysica Acta. 341-345.
  • 1995. Effects of non-beta-oxidizable sulfur-substituted fatty acid analogues on synthesis and secretion of triacylglycerol and cholesterol in cultured rat hepatocytes. Lipids. 987-994.
  • 1995. Acute modulation of rat hepatic lipid metabolism by sulphur-substituted fatty acid analogues. Biochemical Pharmacology. 1013-1022.
  • 1994. Stimulation of fatty acid oxidation by a 3-thia fatty acid reduces triacylglycerol secretion in cultured rat hepatocytes. Journal of Lipid Research. 1395-1404.
  • 1994. Gas chromatographic measurement of 3- and 4-thia fatty acids incorporated into various classes of rat liver during feeding experiments. Journal of chromatography. B. 1-10.
  • 1994. Coordinate induction of hepatic fatty acyl-CoA oxidase and P450A1 in rat after activation of the peroxisome proliferator-activated receptor (PPAR) by sulphur-substituted fatty acid analogues. Xenobiotica. 943-954.
  • 1993. The triglyceride-lowering effect on omega-3 fatty acids. Is it all in eicosapentaenoc acid. Omega-3 News. 5-8.
  • 1993. The hypotriglyceridemic effect of eicosapentaenoic acid in rats is reflected in increased mitochondrial fatty acid oxidation followed by diminished lipogenesis. Lipids. 683-690.
  • 1993. The hypotriglyceridemic effect of eicosapentaenoic acid in rats is reflected in increased mitochondrial fatty acid oxidation followed by diminished lipogenesis. Lipids. 683-690.
  • 1993. The effect of 3-thiadicarboxcylic acid on lipid metabolism in experimental nephrosis. Arteriosclerosis and thrombosis. 1580-1586.
  • 1993. Structural and metaboli requirements for activators of the peroxisome proliferator activated receptor (PPAR). Biochemical Pharmacology. 36-43.
  • 1993. Relationship between peroxisomes proliferating sulfur substituted fatty acid analogues, heatic lipid peroxidation and hydrogen peroxide metabolism. Biochemical Pharmacology. 257-259.
  • 1993. Pretranslational regulation of cytochrome P-450 4A1 by free fatty acids in primary cultures of rat hepatocytes. Journal of Lipid Research. 1758-1791.
  • 1993. On the mechanism of the hypolipidemic effect on sulfur-substituted hexadecanediotic (3-thiadicarboxylic acid) in normolipidemic rats. Journal of Lipid Research. 1177-1185.
  • 1993. Modulation of phosphatidylcholine biosynthesis by peroxisomal proliferating fatty acid analogs. Lipids. 795-801.
  • 1993. Hypolipidemic effect of sulfur-substitutet fatty acid analogues in rats fed a high carbohydrate diet. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 175-183.
  • 1993. Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice. Lipids. 968-971.
  • 1993. Early affects on mitocondrial and peroxisomal beta-oxidation by the hypolipidemic 3-thia fatty acid in rat livers. Biochimica et Biophysica Acta. 73-76.
  • 1993. Docosahexaenoic Acid Shows no Triglyceride-Lowering Effects, but increases the Peroxisomal Fatty Acid Oxidation in Liver of Rats. Journal of Lipid Research. 13-22.
  • 1993. Cholesterol induced lipid accumulation in myocardial cells of rats. Cardiovascular Research (CVR). 442-446.
  • 1993. Allupurinol does not affect the concentration of endogenous glutathione in liver cells in rats after 60 min of normothermic liver ischemia. European Journal of Surgery. 355-359.
  • 1992. The activity and subcellular distribution of the peroxisomal enzyme acyl-CoA oxidase in human bloodplatelets. Biochemical Journal. 829-831.
  • 1992. Relationship between translocation of long-chain acyl-CoA hydrolase, phosphatidate phosphohydrolase and CTP:Phosphocholine cytidylyltransferase and the synthesis of triglycerides and phosphatidylcholine in rat liver. Lipids. 241-147.
  • 1992. Relationship between translocation of long-chain Acyl-CoA hydrolase, phosphatidate phosphohydrolase and CTP: phosphocholine cytidyltransferase and the synthesis of triglycerides and phosphatidylcholine in rat liver. Lipids. 241-247.
  • 1992. Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antiocidant defense in mice. Lipids. 968-972.
  • 1992. Comparative effects of oxygen and sulfur-substituted fatty acids on serum lipids and mitochondrial and peroxisomal fatty acid-oxidation in rat. Biochemical Pharmacology. 815-822.
  • 1992. Camparative effects of oxygen and sulfur-substituted fatty acids on serum lipids and mitochondrial and peroxisomal fatty acid oxidation in rat. Biochemical Pharmacology. 815-822.
  • 1991. Peroxsisome proliferating sulfur - and oxysubstituted fatty acid analogues are activated to coenzyme-A thioesters. Biochemical Pharmacology. 53-61.
  • 1990. The presence of acyl-CoA hydrolase in rat brown-adipose-tissue peroxisomes. Biochemical Journal. 41-46.
  • 1990. The hypolipidemic peroxisome proliferating drug bis (carboxymethylthio)-1.10-decane, a dicarboxylic metabolite of tiadenol, is activated to an acyl-coenzyme A thioester. Biochimica et Biophysica Acta. 176-183.
  • 1990. Regulation of fatty acid oxidation, triglyceride- and phospholipid metabolism by hypolipidemic sulfur-substituted fatty acid and analogues. Journal of Lipid Research. 1627-1635.
  • 1990. On the effect of peroxisomal _b-oxidation and carnitine palmitoyltransferase activity by eicosapentaenoic acid in liver and hearts from rats. Lipids. 546-549.
  • 1990. Morphologic effects of sulfursubstituted fatty acids on rat hepatocytes with special references to proliferation of peroxisomes and mitochondria. Journal of Structural Biology. 257-265.
  • 1990. Fatty acid metabolism in livers of rats treated with hypolipidemic sulphur substituted fatty acid analogues. Role of long-chain acyl-CoA and requirement for stimulated fatty acid oxidation in peroxisomes. Biochimica et Biophysica Acta. 211-221.
  • 1990. Effects of the tumor promoter 12-0-tetradecanoylphorbol-13-acetate, on peroxisomal activities and enzyme activities involved in lipid metabolism in liver. Biochimica et Biophysica Acta. 86-93.
  • 1990. Effects of 3- and 4-thia substituted fatty acids on mitochondrial and peroxisomal _b-oxidation. In vivo and in vitro studies. Biochemical Journal. 321-330.
  • 1990. Effect of 3- and 4-thia-substituted fatty acids on glycerolipid metabolism and mitochondrial beta-oxidation in rat liver. Biochemical Pharmacology. 2005-2012.
Academic lecture
  • 2018. Effect of tetradecylthioacetic acid (TTA) on energy intake and body fat deposition in silver foxes (Vulpes vulpes).
  • 2015. Plasma Interferon-inducible Protein 10 Levels, T-cell Activation and Regulation are Increased in HIV Immunological Non-Responders.
  • 2008. Administration of tetradecylthioacetic acid (TTA) in mice accelerates myocardial FA oxidation via increased expression of pparα target genes.
  • 2006. The Antioxidant,Anti-inflammatory and Hypolipidemic Properties of a Seleno-substituted Fatty Acid.
  • 2005. A pan-PPAR ligand induces differential coactivation of PPARs by SRCs and PGC-1.
  • 2004. Tetradecylthioacetic acid induces ligand dependent coactivation of PPARs by PGC-1 and SRC coactivators.
  • 2004. Different effects of PPAR ligands on cardiac metabolism in mice fed high fat diet.
  • 2004. Decreased TNFα induced endothelial activation in the presence of a new bioactive fatty acid.
  • 2003. Effects of Omega-3 Fatty Acids on DSS-induced Colitis in Rats.
  • 2003. Effect of Ferrous Fumarate Supplementation in Dextran Sulfate Sodium Colitis in Rats.
  • 2001. Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways.
  • 2001. PPAR-activating 3-thia fatty acid influences the growth potential and metabolism in glioma cells.
  • 2001. Expression of PPARa target genes improve insulin action and reduce adiposity.
  • 2001. Dietary treatment of highly concentrated omega-3 fatty acids increases tumor necrosis factor alpha and reduces antioxidant levels in stable heart transplant recipients.
  • 2001. 3-Thia fatty acid induces mitochondrial alterations and triggers apoptosis in cancer cells.
  • 2000. Expression of PPAR alpha target genes improve insulin action and reduce adiposity.
  • 1998. On the antioxidant effect of tetradecylthioacetic acid and tetradecylselenoacetic acid.
  • 1998. Metabolic effects of 3-thia fatty acid in cancer cells.
  • 1998. Antioxidant properties of 3-Thia fatty acids.
  • 1994. Zellweger-like syndrome: Prolonged survival in male twins during treatment with n-3 fatty acids.
Abstract
  • 2012. Combined thermal and electrical muscle stimulation reduce visceral fat and improve lipid profile during weight loss. Circulation. E679-E680.
  • 2010. Low circulating eicosatetraenoic acid and high vaccenic acid are associated with disease severity and predict mortality in heart failure. European Heart Journal. 570-570.
  • 2008. TTA is a pan PPAR ligand which markedly stimulates fatty acid oxidation following in vivo administration. Cardiovascular Drugs and Therapy. 142-143.
  • 2007. The PPAR gamma agonist pioglitazone exaggerates bone loss, while the PPAR alpha agonist fenofibrate maintains BMD and bone architecture in ovarectomized rats. Calcified Tissue International. S40-S40.
  • 2007. Synergistic anti-leukemic effect of protein kinase a activator and PPAR7agonist is independent of Bcl-2 status. Blood. 117B-117B.
  • 2007. In vivo administration of tetradecylthioacetic acid (TTA) in mice causes cardiac inefficiency and reduced post-ischemic ventricular function. Journal of Molecular and Cellular Cardiology.
  • 2007. Health effects from a regular intake of Atlantic salmon in patients with active ulcerative colitis. Scandinavian Journal of Gastroenterology. 26-26.
  • 2006. Indirect and direct effects of PPAR ligands on myocardial metabolism. Journal of Molecular and Cellular Cardiology. 931-932.
  • 2005. Effects of the modified fatty acid tetradecylthioacetic acid (TTA) on an oral cancer progression model. Genomic and proteomic approaches. Oral Oncology. 164-165.
  • 2005. A sulfur-substituted fatty acid analog improves survival and impairs metastasis in rat models of acute leukemia. Experimental Hematology.
  • 2004. Improved insulin sensitivity and reduced adipose tissue mass in relation to mitochondrial function, energy state and PPAR activation. Biochimica et Biophysica Acta - Bioenergetics. 203-203.
  • 2004. Decreased TNF alpha induced endothelial activation in the presence of a new bioactive fatty acid. Chemistry and Physics of Lipids. 39-39.
  • 2004. Cholesterol lowering effect of bioactive proteins. Chemistry and Physics of Lipids. 74-74.
Academic literature review
  • 2011. Tissue-specific effects of bariatric surgery including mitochondrial function. 435245.
  • 2010. The Role of PPAR alpha Activation in Liver and Muscle. 11 pages.

More information in national current research information system (CRIStin)